RecruitingNot Applicable

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)

Norway, Sweden360 participantsStarted 2021-05-17

Plain-language summary

The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Previously included in TACSI-trial Exclusion Criteria: * Highly irregular heart rhythm (i.e. atrial fibrillation) * Chronic kidney disease with estimated glomerular filtration rate (eGFR) \<45ml/min/1,73m2 * Body weight \>120 kg * Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-based contrast agents * Not able to communicate * Not willing to participate

What they're measuring

Graft patency after CABG

Timeframe: 12-36 months

Trial details

NCT IDNCT04783701

SponsorUniversity Hospital, Linkoeping

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-02-01

Contact for this trial

Jonas Holm, MD, PhD

+46101034498 jonas.holm@regionostergotland.se

View on ClinicalTrials.gov More Acute Coronary Syndrome trials